Ophthalmic Devices - Denmark

  • Denmark
  • The Ophthalmic Devices market market in Denmark is forecasted to achieve a revenue of US$113.30m in 2024.
  • It is anticipated that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 3.80%, leading to a market volume of US$136.50m by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of US$14,000.00m in 2024.
  • Denmark is witnessing a growing demand for advanced ophthalmic devices, driven by its strong healthcare infrastructure and aging population.

Key regions: Netherlands, Japan, United States, Spain, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Denmark is experiencing significant growth and development, driven by several key factors.

Customer preferences:
Customers in Denmark are increasingly seeking advanced ophthalmic devices that offer improved precision and accuracy in diagnosing and treating eye conditions. There is a growing demand for devices that can provide non-invasive and painless examinations, as well as those that offer quick and accurate results. Additionally, customers are looking for devices that are user-friendly and can be easily integrated into existing healthcare systems.

Trends in the market:
One of the major trends in the Ophthalmic Devices market in Denmark is the adoption of digital imaging technology. Digital imaging devices, such as optical coherence tomography (OCT) scanners and fundus cameras, are becoming increasingly popular due to their ability to provide high-resolution images of the eye. These devices enable healthcare professionals to accurately diagnose and monitor various eye conditions, leading to improved patient outcomes. Another trend in the market is the increasing use of minimally invasive surgical techniques. Customers are opting for procedures that involve smaller incisions and shorter recovery times. This has led to the development of innovative ophthalmic devices, such as micro-invasive glaucoma surgery (MIGS) devices and femtosecond lasers, which allow for precise and less invasive surgeries.

Local special circumstances:
Denmark has a well-developed healthcare system that provides universal access to healthcare services. This has contributed to the growth of the Ophthalmic Devices market, as patients have easy access to eye care services and are more likely to seek treatment for eye conditions. Additionally, the government of Denmark has implemented policies to promote the use of innovative medical technologies, which has further fueled the growth of the market.

Underlying macroeconomic factors:
The strong economy of Denmark has played a significant role in the development of the Ophthalmic Devices market. A stable economy and high disposable income levels have allowed customers to invest in advanced ophthalmic devices. Moreover, the aging population in Denmark has contributed to the growth of the market, as older individuals are more prone to eye conditions and require regular eye examinations and treatments. In conclusion, the Ophthalmic Devices market in Denmark is witnessing growth and development due to customer preferences for advanced and user-friendly devices, the adoption of digital imaging technology, the increasing use of minimally invasive surgical techniques, the well-developed healthcare system in Denmark, and the underlying macroeconomic factors such as a strong economy and an aging population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)